Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 89R4873 LHC-F | ||
| By: Menéndez | S.B. No. 733 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to the creation of a medical cannabis research program; | |
| authorizing fees. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Subtitle A, Title 6, Health and Safety Code, is | |
| amended by adding Chapter 446 to read as follows: | |
| CHAPTER 446. MEDICAL CANNABIS RESEARCH PROGRAM | |
| SUBCHAPTER A. GENERAL PROVISIONS | |
| Sec. 446.001. SHORT TITLE. This chapter may be cited as the | |
| Medical Cannabis Research Act. | |
| Sec. 446.002. DEFINITIONS. In this chapter: | |
| (1) "Advisory board" means the medical cannabis | |
| research advisory board established under this chapter. | |
| (2) "License" means a medical cannabis research | |
| license issued by the department under Subchapter C. | |
| (3) "License holder" means a person who holds a | |
| medical cannabis research license. | |
| (4) "Medical cannabis" means the plant Cannabis sativa | |
| L., and any part of that plant or any compound, manufacture, salt, | |
| derivative, mixture, preparation, resin, or oil of that plant. The | |
| term does not include hemp, as defined by Section 121.001, | |
| Agriculture Code, or a consumable hemp product, as defined by | |
| Section 443.001 of this code. | |
| SUBCHAPTER B. MEDICAL CANNABIS RESEARCH ADVISORY BOARD | |
| Sec. 446.051. ESTABLISHMENT OF ADVISORY BOARD. (a) A | |
| medical cannabis research advisory board is established to perform | |
| functions and duties under this chapter. | |
| (b) The executive commissioner shall assist the advisory | |
| board as provided by this chapter. | |
| Sec. 446.052. MEMBERSHIP. (a) The advisory board members | |
| are appointed by the governor and serve staggered six-year terms, | |
| with the terms of one-third of the members, or as near to one-third | |
| as possible, expiring on August 31 of each odd-numbered year. | |
| (b) The advisory board shall be composed of the following 11 | |
| members: | |
| (1) a licensed physician certified by the American | |
| Board of Internal Medicine and certified in the subspecialty of | |
| medical oncology; | |
| (2) a licensed physician certified by the American | |
| Board of Surgery; | |
| (3) a licensed physician certified by the American | |
| Board of Psychiatry and Neurology; | |
| (4) a licensed physician certified by the American | |
| Board of Family Medicine; | |
| (5) a licensed physician certified in neurology with a | |
| special qualification in child neurology; | |
| (6) a licensed physician specializing in pain | |
| management certified by the American Board of Anesthesiology, the | |
| American Board of Psychiatry and Neurology, or the American Board | |
| of Physical Medicine and Rehabilitation; | |
| (7) a licensed pharmacist; | |
| (8) a licensed advanced practice registered nurse | |
| specializing in palliative care certified by the Hospice and | |
| Palliative Credentialing Center or a licensed physician | |
| specializing in palliative care certified by a member board of the | |
| American Board of Medical Specialties, the American Osteopathic | |
| Association, or the Hospice Medical Director Certification Board; | |
| (9) a representative from a Texas medical specialty | |
| organization; | |
| (10) a licensed attorney with experience in law | |
| pertaining to the practice of medicine and cannabis regulation; and | |
| (11) a person who represents medical cannabis patient | |
| interests. | |
| (c) At least two members of the advisory board must be | |
| affiliated with an institution of higher education or private or | |
| independent institution of higher education involved in relevant | |
| research, such as a medical and dental unit, general academic | |
| teaching institution, or other agency of higher education, as | |
| defined by Section 61.003, Education Code. | |
| (d) The governor shall select a presiding officer from the | |
| membership of the advisory board. | |
| (e) The advisory board shall meet at least quarterly at the | |
| call of the presiding officer. | |
| (f) The advisory board may create and appoint one or more | |
| advisory committees composed of patients, law enforcement | |
| officers, researchers, other medical professionals, and other | |
| persons who are knowledgeable about the medical use of cannabis. | |
| (g) Members serve without compensation but are entitled to | |
| reimbursement for actual and necessary expenses incurred in | |
| performing official duties. | |
| Sec. 446.053. DUTIES OF ADVISORY BOARD; REPORT. (a) The | |
| advisory board shall assist the department in evaluating proposals | |
| submitted as part of a license application under Section 446.104. | |
| (b) The advisory board shall conduct a continuing study of | |
| the laws relating to medical cannabis to facilitate statewide | |
| access to safe and effective medical cannabis. | |
| (c) The advisory board shall prepare a report of the board's | |
| findings and recommendations under Subsection (b) and submit the | |
| report to the legislature not later than September 1 of each | |
| even-numbered year. | |
| (d) Chapter 2110, Government Code, does not apply to the | |
| advisory board. | |
| SUBCHAPTER C. MEDICAL CANNABIS RESEARCH LICENSE | |
| Sec. 446.101. ISSUANCE OF LICENSE. The department shall | |
| issue a medical cannabis research license to a person that | |
| authorizes the person to possess, manufacture, cultivate, or | |
| dispense medical cannabis for the limited research purposes | |
| described by Section 446.102. | |
| Sec. 446.102. PURPOSE OF LICENSE. A medical cannabis | |
| research license may be issued for the following limited research | |
| purposes: | |
| (1) conducting objective scientific research into the | |
| safety and efficacy of medical cannabis or other public health | |
| outcomes related to medical cannabis; | |
| (2) developing medical guidelines for the appropriate | |
| administration of medical cannabis to assist physicians and | |
| patients in evaluating the risks and benefits of medical cannabis | |
| and to provide a scientific basis for future policies; | |
| (3) developing quality control, purity, and labeling | |
| standards for medical cannabis; | |
| (4) developing best practices for the safe and | |
| efficient cultivation of medical cannabis; | |
| (5) analyzing genetic and healing properties of | |
| different varieties of cannabis; | |
| (6) conducting genomic, horticultural, or | |
| agricultural research; and | |
| (7) conducting research on cannabis-affiliated | |
| products or systems. | |
| Sec. 446.103. APPLICATION FOR LICENSE. (a) As part of the | |
| application process for a license, an applicant shall submit to the | |
| department and the advisory board a description of the research | |
| that the applicant intends to conduct. The department shall grant | |
| the license if: | |
| (1) the department determines that the application | |
| meets the criteria for the issuance of a license described by | |
| Section 446.102 and Subchapter C, Chapter 487; and | |
| (2) the advisory board recommends the application for | |
| approval under Section 446.104(b). | |
| (b) The department may not grant a license if the advisory | |
| board does not recommend the application for approval. | |
| Sec. 446.104. REVIEW BY ADVISORY BOARD. (a) The advisory | |
| board shall review each applicant's research project to assess the | |
| following: | |
| (1) the quality, study design, value, and impact of | |
| the project; | |
| (2) whether the research supports the purposes | |
| described by Section 446.102; | |
| (3) whether the applicant has the appropriate | |
| personnel, expertise, facilities, infrastructure, funding, and | |
| approvals in place to successfully conduct the project; and | |
| (4) whether the amount of cannabis to be grown by the | |
| applicant is consistent with the scope and goals of the project. | |
| (b) If the advisory board determines that the research | |
| project meets the requirements of this subchapter and the applicant | |
| satisfies the criteria described by Subsection (a), the advisory | |
| board may recommend that a license be granted to the applicant for | |
| the project. | |
| Sec. 446.105. CONTRACTS. A license holder may contract to | |
| perform research in conjunction with another license holder, a | |
| medical school, as defined by Section 61.501, Education Code, a | |
| hospital licensed under Chapter 241, or an institution of higher | |
| education or private or independent institution of higher education | |
| involved in relevant research, such as a general academic teaching | |
| institution, medical and dental unit, or other agency of higher | |
| education, as defined by Section 61.003, Education Code. | |
| Sec. 446.106. TRANSFER OF CANNABIS TO OTHER LICENSE HOLDER. | |
| Unless otherwise authorized by the department, a license holder may | |
| only transfer, by sale or donation, cannabis grown or processed | |
| within the license holder's operation to another license holder or | |
| program participant as authorized by department rule. | |
| Sec. 446.107. LIMITATION OF LIABILITY. The growing, | |
| cultivating, possessing, or transferring, by sale or donation, of | |
| cannabis in accordance with this subchapter and the rules adopted | |
| under this subchapter, by a license holder may not be the basis of | |
| criminal or civil liability. | |
| Sec. 446.108. FEES. The executive commissioner shall set | |
| license and renewal fees in an amount sufficient to administer this | |
| chapter. | |
| Sec. 446.109. RULES. The executive commissioner shall, in | |
| consultation with the advisory board and the Public Safety | |
| Commission of the Department of Public Safety, adopt rules to | |
| implement this chapter, including: | |
| (1) license application requirements; | |
| (2) license renewal requirements, including the | |
| consideration or addition of additional research projects by a | |
| license holder; | |
| (3) grounds for license revocation; | |
| (4) security measures to ensure cannabis is not | |
| diverted to purposes other than research; | |
| (5) license holder reporting requirements; | |
| (6) conditions under which cannabis grown by licensed | |
| cannabis cultivators and other product types from licensed cannabis | |
| processors may be donated to license holders; and | |
| (7) additional rules the executive commissioner | |
| considers necessary. | |
| SECTION 2. Section 481.062(a), Health and Safety Code, is | |
| amended to read as follows: | |
| (a) The following persons may possess a controlled | |
| substance under this chapter without registering with the Federal | |
| Drug Enforcement Administration: | |
| (1) an agent or employee of a manufacturer, | |
| distributor, analyzer, or dispenser of the controlled substance who | |
| is registered with the Federal Drug Enforcement Administration and | |
| acting in the usual course of business or employment; | |
| (2) a common or contract carrier, a warehouseman, or | |
| an employee of a carrier or warehouseman whose possession of the | |
| controlled substance is in the usual course of business or | |
| employment; | |
| (3) an ultimate user or a person in possession of the | |
| controlled substance under a lawful order of a practitioner or in | |
| lawful possession of the controlled substance if it is listed in | |
| Schedule V; | |
| (4) an officer or employee of this state, another | |
| state, a political subdivision of this state or another state, or | |
| the United States who is lawfully engaged in the enforcement of a | |
| law relating to a controlled substance or drug or to a customs law | |
| and authorized to possess the controlled substance in the discharge | |
| of the person's official duties; | |
| (5) if the substance is tetrahydrocannabinol or one of | |
| its derivatives: | |
| (A) a Department of State Health Services | |
| official, a medical school researcher, or a research program | |
| participant possessing the substance as authorized under | |
| Subchapter G; or | |
| (B) a practitioner or an ultimate user possessing | |
| the substance as a participant in a federally approved therapeutic | |
| research program that the commissioner has reviewed and found, in | |
| writing, to contain a medically responsible research protocol; [ |
|
| (6) a dispensing organization licensed under | |
| Subchapter C, Chapter 487 that possesses low-THC cannabis; or | |
| (7) a medical cannabis research license holder under | |
| Chapter 446 that possesses medical cannabis. | |
| SECTION 3. Section 551.004(a), Occupations Code, is amended | |
| to read as follows: | |
| (a) This subtitle does not apply to: | |
| (1) a practitioner licensed by the appropriate state | |
| board who supplies a patient of the practitioner with a drug in a | |
| manner authorized by state or federal law and who does not operate a | |
| pharmacy for the retailing of prescription drugs; | |
| (2) a member of the faculty of a college of pharmacy | |
| recognized by the board who is a pharmacist and who performs the | |
| pharmacist's services only for the benefit of the college; | |
| (3) a person who procures prescription drugs for | |
| lawful research, teaching, or testing and not for resale; | |
| (4) a home and community support services agency that | |
| possesses a dangerous drug as authorized by Section 142.0061, | |
| 142.0062, or 142.0063, Health and Safety Code; [ |
|
| (5) a dispensing organization, as defined by Section | |
| 487.001, Health and Safety Code, that cultivates, processes, and | |
| dispenses low-THC cannabis, as authorized by a license issued under | |
| Subchapter C, Chapter 487, Health and Safety Code, to a patient | |
| listed in the compassionate-use registry established under that | |
| chapter; or | |
| (6) a medical cannabis research license holder under | |
| Chapter 446, Health and Safety Code, that cultivates, possesses, | |
| researches, tests, and dispenses medical cannabis as authorized by | |
| the license. | |
| SECTION 4. Not later than December 31, 2025, the executive | |
| commissioner of the Health and Human Services Commission shall | |
| adopt rules as required to implement, administer, and enforce this | |
| Act. | |
| SECTION 5. The governor shall appoint members to the | |
| medical cannabis research advisory board as required under Chapter | |
| 446, Health and Safety Code, as added by this Act, as soon as | |
| practicable but not later than September 1, 2025. | |
| SECTION 6. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.